dc.creator | Forouzanfar F. | |
dc.creator | Butler A.E. | |
dc.creator | Banach M. | |
dc.creator | Barreto G.E. | |
dc.creator | Sahbekar A. | |
dc.date.accessioned | 2020-09-02T22:17:57Z | |
dc.date.accessioned | 2022-11-08T20:24:00Z | |
dc.date.available | 2020-09-02T22:17:57Z | |
dc.date.available | 2022-11-08T20:24:00Z | |
dc.date.created | 2020-09-02T22:17:57Z | |
dc.date.issued | 2018 | |
dc.identifier | 134, , 134-144 | |
dc.identifier | 10436618 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4516 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145085 | |
dc.language | en | |
dc.publisher | Academic Press | |
dc.subject | Atherogenesis | |
dc.subject | Heat shock proteins | |
dc.subject | HMG-CoA | |
dc.subject | Statin | |
dc.subject | alpha crystallin | |
dc.subject | atorvastatin | |
dc.subject | beta crystallin | |
dc.subject | C reactive protein | |
dc.subject | calnexin | |
dc.subject | calreticulin | |
dc.subject | cerivastatin | |
dc.subject | chaperonin 60 | |
dc.subject | cholesterol | |
dc.subject | fluindostatin | |
dc.subject | glucose regulated protein 78 | |
dc.subject | glycoprotein gp 96 | |
dc.subject | heat shock cognate protein 70 | |
dc.subject | heat shock protein | |
dc.subject | heat shock protein 110 | |
dc.subject | heat shock protein 27 | |
dc.subject | heat shock protein 40 | |
dc.subject | heat shock protein 47 | |
dc.subject | heat shock protein 70 | |
dc.subject | heat shock protein 90 | |
dc.subject | high density lipoprotein cholesterol | |
dc.subject | hydroxymethylglutaryl coenzyme A reductase | |
dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | |
dc.subject | isoprenoid | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | mevinolin | |
dc.subject | rosuvastatin | |
dc.subject | simvastatin | |
dc.subject | triacylglycerol | |
dc.subject | unindexed drug | |
dc.subject | heat shock protein | |
dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | |
dc.subject | lipid | |
dc.subject | angiogenesis | |
dc.subject | atherosclerosis | |
dc.subject | cardiovascular disease | |
dc.subject | cholesterol blood level | |
dc.subject | cholesterol synthesis | |
dc.subject | drug mechanism | |
dc.subject | human | |
dc.subject | hypercholesterolemia | |
dc.subject | modulation | |
dc.subject | pleiotropy | |
dc.subject | priority journal | |
dc.subject | protein function | |
dc.subject | protein localization | |
dc.subject | Review | |
dc.subject | risk factor | |
dc.subject | triacylglycerol blood level | |
dc.subject | animal | |
dc.subject | blood | |
dc.subject | cardiovascular disease | |
dc.subject | complication | |
dc.subject | drug effect | |
dc.subject | dyslipidemia | |
dc.subject | metabolism | |
dc.subject | signal transduction | |
dc.subject | Animals | |
dc.subject | Cardiovascular Diseases | |
dc.subject | Dyslipidemias | |
dc.subject | Heat-Shock Proteins | |
dc.subject | Humans | |
dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
dc.subject | Lipids | |
dc.subject | Signal Transduction | |
dc.title | Modulation of heat shock proteins by statins | |
dc.type | Review | |